HYDROCORTISONE ACETATE AND PRAMOXINE HYDROCHLORIDE

HYDROCORTISONE ACETATE AND PRAMOXINE HYDROCHLORIDE was reported 212 times

HYDROCORTISONE ACETATE AND PRAMOXINE HYDROCHLORIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 POIKILODERMA 3 0.0278
1 CORNEAL OPERATION 2 0.0194
2 JC VIRUS GRANULE CELL NEURONOPATHY 1 0.0185
3 ISCHAEMIC ULCER 1 0.0167
4 PULMONARY RADIATION INJURY 1 0.0164
5 MORTON'S NEUROMA 1 0.0152
6 PULMONARY ENDARTERECTOMY 2 0.0137
7 DYSKINESIA OESOPHAGEAL 1 0.0112
8 SALPINGO-OOPHORECTOMY UNILATERAL 1 0.0091
9 FIBROUS HISTIOCYTOMA 3 0.0085
10 SOMATISATION DISORDER 1 0.0076
11 URINARY STRAINING 1 0.0072
12 SKIN MACERATION 1 0.0065
13 LENTIGO 3 0.0060
14 OVARIAN EPITHELIAL CANCER 1 0.0052
15 ENDARTERECTOMY 1 0.0045
16 METATARSALGIA 1 0.0042
17 DUMPING SYNDROME 1 0.0038
18 BILE ACID MALABSORPTION 1 0.0035
19 MORGANELLA INFECTION 1 0.0034
20 CEREBRAL ARTERIOSCLEROSIS 1 0.0026
21 AMMONIA ABNORMAL 1 0.0025
22 HEARING AID USER 1 0.0023
23 HIP DEFORMITY 1 0.0023
24 PIGMENTARY MACULOPATHY 1 0.0021
25 LABELLED DRUG-FOOD INTERACTION MEDICATION ERROR 1 0.0020
26 EPHELIDES 1 0.0019
27 DROP ATTACKS 1 0.0017
28 CAROTID ARTERY DISEASE 2 0.0016
29 ANAL INFLAMMATION 1 0.0016
30 SOCIAL ANXIETY DISORDER 1 0.0015
31 RENAL ARTERY STENOSIS 2 0.0015
32 BORDERLINE PERSONALITY DISORDER 1 0.0014
33 ATROPHIC VULVOVAGINITIS 1 0.0014
34 MICTURITION FREQUENCY DECREASED 1 0.0013
35 GINGIVAL ULCERATION 1 0.0013
36 RETINAL PIGMENTATION 1 0.0013
37 SINUSITIS FUNGAL 1 0.0012
38 EXCESSIVE GRANULATION TISSUE 1 0.0012
39 APPLICATION SITE DISCOMFORT 2 0.0011
40 PRIMARY SEQUESTRUM 1 0.0011
41 URINARY TRACT INFECTION ENTEROCOCCAL 1 0.0011
42 SKIN HYPERTROPHY 3 0.0011
43 TELANGIECTASIA 1 0.0010
44 PNEUMONIA STAPHYLOCOCCAL 2 0.0010
45 NON-ALCOHOLIC STEATOHEPATITIS 1 0.0010
46 SUBSTANCE-INDUCED PSYCHOTIC DISORDER 2 0.0009
47 FOLATE DEFICIENCY 1 0.0009
48 ACUTE PRERENAL FAILURE 1 0.0009
49 BLADDER PROLAPSE 1 0.0008
50 MALLORY-WEISS SYNDROME 1 0.0008
51 APPLICATION SITE WARMTH 1 0.0008
52 OVARIAN CYST RUPTURED 1 0.0008
53 ACROCHORDON 1 0.0008
54 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 1 0.0007
55 CALCULUS BLADDER 1 0.0007
56 RHONCHI 1 0.0007
57 APPLICATION SITE INFLAMMATION 1 0.0007
58 DISCHARGE 1 0.0007
59 CULTURE URINE POSITIVE 1 0.0007
60 OBSTRUCTIVE SLEEP APNOEA SYNDROME 1 0.0007
61 MELANOCYTIC NAEVUS 3 0.0007
62 NORMOCYTIC ANAEMIA 1 0.0007
63 SECONDARY ADRENOCORTICAL INSUFFICIENCY 1 0.0007
64 AGE-RELATED MACULAR DEGENERATION 1 0.0007
65 CHEST X-RAY ABNORMAL 2 0.0007
66 DIASTOLIC DYSFUNCTION 2 0.0006
67 INTERMITTENT CLAUDICATION 1 0.0006
68 COSTOCHONDRITIS 1 0.0006
69 SHOULDER FRACTURE 1 0.0006
70 SKIN WOUND 1 0.0006
71 FEMALE GENITAL TRACT FISTULA 1 0.0006
72 ACUTE SINUSITIS 1 0.0006
73 SERUM FERRITIN DECREASED 1 0.0006
74 WOUND INFECTION STAPHYLOCOCCAL 1 0.0006
75 VERTIGO POSITIONAL 1 0.0006
76 INFUSION SITE DISCHARGE 1 0.0006
77 POLYMYOSITIS 1 0.0006
78 JUGULAR VEIN THROMBOSIS 1 0.0006
79 CEREBRAL VENOUS THROMBOSIS 1 0.0006
80 SUSPECTED PRODUCT QUALITY ISSUE 1 0.0005
81 OESOPHAGEAL SPASM 1 0.0005
82 LOBAR PNEUMONIA 1 0.0005
83 BLOOD BICARBONATE DECREASED 1 0.0005
84 CONVERSION DISORDER 1 0.0005
85 PNEUMONIA CYTOMEGALOVIRAL 1 0.0005
86 PROSTATOMEGALY 2 0.0005
87 ANORECTAL DISORDER 1 0.0005
88 SKIN PAPILLOMA 2 0.0005
89 MUCOSAL DRYNESS 1 0.0005
90 APPLICATION SITE DISCOLOURATION 2 0.0005
91 SKIN INDURATION 1 0.0005
92 INTESTINAL STENOSIS 2 0.0005
93 NEUROGENIC BLADDER 1 0.0005
94 LEFT VENTRICULAR HYPERTROPHY 2 0.0005
95 HYPERPHOSPHATAEMIA 1 0.0005
96 APPLICATION SITE SCAB 1 0.0005
97 SPUTUM INCREASED 1 0.0005
98 EXPOSED BONE IN JAW 1 0.0005
99 GASTRIC BYPASS 1 0.0005
100 TONGUE DISCOLOURATION 2 0.0005
101 LIMB MASS 1 0.0005
102 CATHETERISATION CARDIAC 2 0.0005
103 PERIARTHRITIS 1 0.0004
104 CROHN'S DISEASE 3 0.0004
105 APHTHOUS STOMATITIS 1 0.0004
106 PULMONARY INFARCTION 1 0.0004
107 URINARY TRACT OBSTRUCTION 1 0.0004
108 RASH VESICULAR 2 0.0004
109 BREATH SOUNDS ABNORMAL 2 0.0004
110 EYELID IRRITATION 1 0.0004
111 PROTEIN TOTAL INCREASED 1 0.0004
112 ANGIONEUROTIC OEDEMA 1 0.0004
113 TEMPOROMANDIBULAR JOINT SYNDROME 1 0.0004
114 ANAL FISSURE 2 0.0004
115 ANAESTHETIC COMPLICATION 1 0.0004
116 APPLICATION SITE RASH 5 0.0004
117 THYROID NEOPLASM 1 0.0004
118 PLEURITIC PAIN 1 0.0004
119 SERUM SICKNESS 1 0.0004
120 OXYGEN SATURATION ABNORMAL 1 0.0004
121 RESPIRATORY SYMPTOM 1 0.0004
122 VITAMIN B12 DECREASED 1 0.0003
123 HYPOVOLAEMIA 2 0.0003
124 URINE ANALYSIS ABNORMAL 1 0.0003
125 SQUAMOUS CELL CARCINOMA OF SKIN 2 0.0003
126 NEPHROGENIC SYSTEMIC FIBROSIS 1 0.0003
127 EMBOLISM VENOUS 1 0.0003
128 DERMATITIS ACNEIFORM 2 0.0003
129 VULVOVAGINAL BURNING SENSATION 2 0.0003
130 MASTICATION DISORDER 1 0.0003
131 IRON DEFICIENCY ANAEMIA 3 0.0003
132 EYELIDS PRURITUS 1 0.0003
133 PRE-EXISTING CONDITION IMPROVED 2 0.0003
134 INFUSION SITE PRURITUS 1 0.0003
135 LOOSE TOOTH 1 0.0003
136 DEAFNESS NEUROSENSORY 1 0.0003
137 PLANTAR FASCIITIS 1 0.0003
138 BK VIRUS INFECTION 1 0.0003
139 PRODUCT CONTAMINATION 1 0.0003
140 SKIN WEEPING 1 0.0003
141 FRUSTRATION 1 0.0003
142 RASH PUSTULAR 2 0.0003
143 OESOPHAGITIS 3 0.0003
144 MOUTH HAEMORRHAGE 2 0.0003
145 RECTAL DISCHARGE 1 0.0003
146 FREEZING PHENOMENON 1 0.0003
147 CHRONIC SINUSITIS 1 0.0003
148 FACE INJURY 1 0.0003
149 TRICUSPID VALVE INCOMPETENCE 2 0.0003
150 BLEPHARITIS 1 0.0002
151 PERIPHERAL ISCHAEMIA 1 0.0002
152 TRIGGER FINGER 1 0.0002
153 APPLICATION SITE EXFOLIATION 1 0.0002
154 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 2 0.0002
155 ONYCHOMADESIS 1 0.0002
156 UTERINE PERFORATION 2 0.0002
157 TONGUE DISCOMFORT 1 0.0002
158 ESCHERICHIA URINARY TRACT INFECTION 1 0.0002
159 POOR PERIPHERAL CIRCULATION 1 0.0002
160 PRODUCT DISPENSING ISSUE 1 0.0002
161 HEPATIC LESION 1 0.0002
162 DIVERTICULUM INTESTINAL 1 0.0002
163 DYSPHEMIA 1 0.0002
164 URINE ABNORMALITY 1 0.0002
165 EAR DISORDER 1 0.0002
166 ISCHAEMIA 1 0.0002
167 ROSACEA 1 0.0002
168 GASTRITIS EROSIVE 1 0.0002
169 FLANK PAIN 2 0.0002
170 ENDOMETRIOSIS 1 0.0002
171 SLEEP APNOEA SYNDROME 4 0.0002
172 GUILLAIN-BARRE SYNDROME 1 0.0002
173 HAEMORRHOIDAL HAEMORRHAGE 1 0.0002
174 INFLAMMATORY BOWEL DISEASE 2 0.0002
175 NASAL POLYPS 1 0.0002
176 DIABETIC NEUROPATHY 1 0.0002
177 ANEURYSM 1 0.0002
178 APPLICATION SITE SWELLING 1 0.0002
179 CORONARY ARTERY STENOSIS 1 0.0002
180 TOE AMPUTATION 1 0.0002
181 DRY THROAT 2 0.0002
182 INITIAL INSOMNIA 2 0.0002
183 CEREBRAL ISCHAEMIA 1 0.0002
184 VARICOSE VEIN 1 0.0002
185 INCONTINENCE 2 0.0002
186 IRRITABLE BOWEL SYNDROME 4 0.0002
187 BRUXISM 1 0.0002
188 GINGIVITIS 1 0.0002
189 CHEILITIS 1 0.0002
190 FAECALOMA 1 0.0002
191 INTESTINAL ISCHAEMIA 1 0.0002
192 CHOKING SENSATION 1 0.0002
193 HYPERKERATOSIS 1 0.0002
194 OBSTRUCTIVE AIRWAYS DISORDER 2 0.0002
195 FISTULA 2 0.0002
196 MITRAL VALVE INCOMPETENCE 2 0.0002
197 EXERCISE TOLERANCE DECREASED 1 0.0002
198 BLOOD URIC ACID INCREASED 1 0.0002
199 METASTASES TO LUNG 2 0.0002
200 METABOLIC DISORDER 1 0.0002
201 PRODUCT LABEL CONFUSION 1 0.0002
202 HYPERLIPIDAEMIA 2 0.0002
203 SYMPTOM RECURRENCE 1 0.0002
204 ACUTE RESPIRATORY FAILURE 3 0.0002
205 PROCTALGIA 1 0.0002
206 ANGINA UNSTABLE 1 0.0002
207 HAEMORRHOIDS 3 0.0002
208 SKIN FISSURES 3 0.0002
209 APPLICATION SITE ERYTHEMA 4 0.0002
210 PRODUCT PREPARATION ISSUE 1 0.0002
211 APPETITE DISORDER 1 0.0002
212 CHOLECYSTITIS CHRONIC 1 0.0001
213 POST-TRAUMATIC STRESS DISORDER 1 0.0001
214 BREAST MASS 1 0.0001
215 IMPAIRED GASTRIC EMPTYING 2 0.0001
216 ECCHYMOSIS 1 0.0001
217 MENTAL STATUS CHANGES 4 0.0001
218 DEVICE OCCLUSION 2 0.0001
219 DIVERTICULUM 1 0.0001
220 MAJOR DEPRESSION 1 0.0001
221 APPLICATION SITE PAIN 3 0.0001
222 LOWER GASTROINTESTINAL HAEMORRHAGE 1 0.0001
223 SKIN HAEMORRHAGE 2 0.0001
224 HYDRONEPHROSIS 1 0.0001
225 APPLICATION SITE PRURITUS 3 0.0001
226 CORONARY ARTERY DISEASE 4 0.0001
227 CHRONIC KIDNEY DISEASE 10 0.0001
228 AORTIC ANEURYSM 1 0.0001
229 FOOD ALLERGY 1 0.0001
230 ARTERIAL OCCLUSIVE DISEASE 1 0.0001
231 RENAL CYST 1 0.0001
232 RASH ERYTHEMATOUS 6 0.0001
233 RHINITIS 1 0.0001
234 STENT PLACEMENT 1 0.0001
235 POLYURIA 1 0.0001
236 BLOOD UREA INCREASED 2 0.0001
237 HAEMODIALYSIS 1 0.0001
238 INFUSION SITE ERYTHEMA 1 0.0001
239 SKIN PLAQUE 1 0.0001
240 RENAL FAILURE ACUTE 5 0.0001
241 SCAR 2 0.0001
242 SKIN HYPERPIGMENTATION 1 0.0001
243 MUSCULOSKELETAL DISCOMFORT 2 0.0001
244 ANURIA 1 0.0001
245 PSYCHOLOGICAL TRAUMA 1 0.0001
246 HYSTERECTOMY 1 0.0001
247 ORTHOSTATIC HYPOTENSION 2 0.0001
248 BLOOD CALCIUM INCREASED 1 0.0001
249 TUMOUR LYSIS SYNDROME 1 0.0001
250 BLOOD TRIGLYCERIDES INCREASED 2 0.0001
251 ACUTE RESPIRATORY DISTRESS SYNDROME 2 0.0001
252 EAR INFECTION 3 0.0001
253 MYOSITIS 1 0.0001
254 PAIN OF SKIN 3 0.0001
255 OSTEOMYELITIS 2 0.0001
256 OPTIC NEURITIS 1 0.0001
257 EXOSTOSIS 1 0.0001
258 SKIN LESION 3 0.0001
259 INTERVERTEBRAL DISC DEGENERATION 1 0.0001
260 PRODUCT DISTRIBUTION ISSUE 1 0.0001
261 HEPATIC ENCEPHALOPATHY 1 0.0001
262 DIARRHOEA HAEMORRHAGIC 1 0.0001
263 PHOTOPHOBIA 2 0.0001
264 SUPRAVENTRICULAR TACHYCARDIA 1 0.0001
265 AFFECT LABILITY 1 0.0001
266 ATELECTASIS 1 0.0001
267 ERUCTATION 2 0.0001
268 VITAMIN D DEFICIENCY 1 0.0001
269 KNEE OPERATION 1 0.0001
270 LIGAMENT SPRAIN 1 0.0001
271 ACTIVITIES OF DAILY LIVING IMPAIRED 2 0.0001
272 PRESCRIBED UNDERDOSE 2 0.0001
273 HYPOTONIA 1 0.0001
274 DRY EYE 5 0.0001
275 EMPHYSEMA 1 0.0001
276 FEEDING DISORDER 2 0.0001
277 PSORIATIC ARTHROPATHY 4 0.0001
278 TOOTH ABSCESS 1 0.0001
279 SUBARACHNOID HAEMORRHAGE 1 0.0001
280 SLUGGISHNESS 1 0.0001
281 EYE DISCHARGE 1 0.0001
282 POOR QUALITY PRODUCT ADMINISTERED 1 0.0001
283 BODY HEIGHT DECREASED 1 0.0001
284 PHARYNGITIS STREPTOCOCCAL 1 0.0001
285 BACK INJURY 1 0.0001
286 INTERVERTEBRAL DISC PROTRUSION 2 0.0001
287 ASPIRATION 1 0.0001
288 STAPHYLOCOCCAL INFECTION 3 0.0001
289 INJECTION SITE NODULE 1 0.0001
290 SKIN INFECTION 1 0.0001
291 BLOOD CALCIUM DECREASED 1 0.0001
292 IMPAIRED DRIVING ABILITY 1 0.0001
293 SCAB 1 0.0001
294 CHOLECYSTECTOMY 1 0.0001
295 GASTROOESOPHAGEAL REFLUX DISEASE 7 0.0001
296 RASH MACULAR 3 0.0001
297 ATAXIA 1 0.0001
298 NEUROPATHY PERIPHERAL 8 0.0001
299 NO THERAPEUTIC RESPONSE 1 0.0001
300 MUSCLE SPASTICITY 1 0.0001
301 HYPERCALCAEMIA 1 0.0001
302 ABASIA 2 0.0001
303 APPLICATION SITE IRRITATION 1 0.0001
304 INJECTION SITE DISCOLOURATION 1 0.0001
305 DERMATITIS ALLERGIC 1 0.0001
306 COLITIS 3 0.0001
307 INJECTION SITE IRRITATION 1 0.0001
308 HIATUS HERNIA 1 0.0001
309 DEEP VEIN THROMBOSIS 5 0.0001
310 PSORIASIS 10 0.0001
311 ORAL CANDIDIASIS 1 0.0001
312 SARS-COV-2 TEST POSITIVE 1 0.0001
313 EYE HAEMORRHAGE 1 0.0001
314 JOINT RANGE OF MOTION DECREASED 1 0.0001
315 QUALITY OF LIFE DECREASED 1 0.0001
316 THROAT TIGHTNESS 2 0.0001
317 TACHYPNOEA 1 0.0001
318 CORONARY ARTERY OCCLUSION 1 0.0001
319 HYPOMAGNESAEMIA 1 0.0001
320 COORDINATION ABNORMAL 1 0.0001
321 WOUND 2 0.0001
322 MASS 1 0.0001
323 CARPAL TUNNEL SYNDROME 1 0.0001
324 BURNING SENSATION 5 0.0001
325 DIALYSIS 1 0.0001
326 RED BLOOD CELL COUNT DECREASED 2 0.0001
327 RECTAL HAEMORRHAGE 3 0.0001
328 SKIN BURNING SENSATION 5 0.0001
329 HYPERSOMNIA 2 0.0001
330 IMPAIRED QUALITY OF LIFE 1 0.0001
331 CHEST DISCOMFORT 7 0.0001
332 SINUSITIS 7 0.0001
333 CARDIOMYOPATHY 1 0.0001
334 BONE LOSS 1 0.0001
335 HYPOAESTHESIA ORAL 1 0.0001
336 NEPHROLITHIASIS 3 0.0001
337 INSURANCE ISSUE 1 0.0001
338 PHARYNGEAL OEDEMA 1 0.0001
339 OROPHARYNGEAL PAIN 6 0.0001
340 MUSCULOSKELETAL CHEST PAIN 1 0.0001
341 ANKLE FRACTURE 1 0.0001
342 URINARY TRACT INFECTION 11 0.0001
343 ACUTE MYELOID LEUKAEMIA 1 0.0001
344 HEAD INJURY 2 0.0001
345 BLOOD LACTATE DEHYDROGENASE INCREASED 1 0.0001
346 PRODUCTIVE COUGH 3 0.0001
347 OBESITY 1 0.0001
348 SWELLING FACE 4 0.0001
349 BLOOD CREATININE INCREASED 4 0.0001
350 IMPAIRED HEALING 2 0.0001
351 VENTRICULAR TACHYCARDIA 1 0.0001
352 THERAPEUTIC RESPONSE SHORTENED 2 0.0001
353 FUNGAL INFECTION 2 0.0001
354 DRY SKIN 8 0.0001
355 CELLULITIS 3 0.0001
356 CANDIDA INFECTION 1 0.0001
357 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 1 0.0001
358 CIRCULATORY COLLAPSE 1 0.0001
359 MULTI-ORGAN FAILURE 1 0.0001
360 ECZEMA 3 0.0001
361 HYPERKALAEMIA 2 0.0001
362 AMENORRHOEA 1 0.0001
363 INJURY 4 0.0001
364 DERMATITIS ATOPIC 3 0.0001
365 HEAD DISCOMFORT 1 0.0001
366 DRUG ERUPTION 1 0.0001
367 ISCHAEMIC STROKE 1 0.0001
368 RASH PRURITIC 3 0.0001
369 TOOTHACHE 1 0.0001
370 PELVIC PAIN 1 0.0001
371 RESTLESS LEGS SYNDROME 1 0.0001
372 DYSURIA 2 0.0001
373 BRONCHITIS 4 0.0001
374 NECK PAIN 3 0.0001
375 MIDDLE INSOMNIA 1 0.0001
376 DYSPNOEA EXERTIONAL 2 0.0001
377 FOOT FRACTURE 1 0.0001
378 BLOOD URINE PRESENT 1 0.0001
379 EAR PAIN 1 0.0001
380 DYSPHONIA 3 0.0001
381 CHOKING 1 0.0001
382 KIDNEY INFECTION 1 0.0001
383 MENORRHAGIA 1 0.0001
384 HAEMATOCRIT DECREASED 1 0.0001
385 UPPER LIMB FRACTURE 1 0.0001
386 PLEURAL EFFUSION 3 0.0000
387 DEVICE BREAKAGE 2 0.0000
388 FEELING HOT 3 0.0000
389 TREATMENT FAILURE 4 0.0000
390 PULMONARY HYPERTENSION 1 0.0000
391 DERMATITIS 1 0.0000
392 HALLUCINATION, VISUAL 1 0.0000
393 OSTEOARTHRITIS 2 0.0000
394 EATING DISORDER 1 0.0000
395 SKIN CANCER 1 0.0000
396 AMNESIA 3 0.0000
397 PRODUCT PRESCRIBING ISSUE 1 0.0000
398 MELAENA 1 0.0000
399 TRANSAMINASES INCREASED 1 0.0000
400 TOOTH DISORDER 1 0.0000
401 RASH MACULO-PAPULAR 1 0.0000
402 COLITIS ULCERATIVE 2 0.0000
403 HEART RATE IRREGULAR 1 0.0000
404 SKIN DISCOLOURATION 2 0.0000
405 MUSCLE TWITCHING 1 0.0000
406 UPPER RESPIRATORY TRACT INFECTION 2 0.0000
407 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 1 0.0000
408 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 3 0.0000
409 PULMONARY EMBOLISM 4 0.0000
410 BLOOD PRESSURE FLUCTUATION 1 0.0000
411 PRURITUS 16 0.0000
412 CONTUSION 4 0.0000
413 INSOMNIA 11 0.0000
414 FIBROMYALGIA 1 0.0000
415 PRESYNCOPE 1 0.0000
416 OSTEONECROSIS OF JAW 1 0.0000
417 LEUKOPENIA 2 0.0000
418 UNEVALUABLE EVENT 3 0.0000
419 ABDOMINAL PAIN LOWER 1 0.0000
420 HAEMATEMESIS 1 0.0000
421 FLUSHING 4 0.0000
422 RASH 17 0.0000
423 HAEMOGLOBIN DECREASED 4 0.0000
424 ERYTHEMA 8 0.0000
425 UNRESPONSIVE TO STIMULI 1 0.0000
426 RASH GENERALISED 1 0.0000
427 HAEMATOMA 1 0.0000
428 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 2 0.0000
429 ABDOMINAL DISTENSION 4 0.0000
430 ANHEDONIA 1 0.0000
431 DEPRESSED MOOD 2 0.0000
432 CARDIAC FAILURE CONGESTIVE 3 0.0000
433 DISTURBANCE IN ATTENTION 2 0.0000
434 FREQUENT BOWEL MOVEMENTS 1 0.0000
435 OEDEMA 2 0.0000
436 PNEUMONITIS 1 0.0000
437 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 2 0.0000
438 MEMORY IMPAIRMENT 5 0.0000
439 CARDIAC ARREST 3 0.0000
440 RESPIRATORY DISTRESS 1 0.0000
441 PANCYTOPENIA 2 0.0000
442 BLISTER 2 0.0000
443 SKIN EXFOLIATION 3 0.0000
444 EYE PAIN 2 0.0000
445 ASTHMA 4 0.0000
446 MUSCULAR WEAKNESS 4 0.0000
447 ANXIETY 10 0.0000
448 ANGINA PECTORIS 1 0.0000
449 HERPES ZOSTER 2 0.0000
450 BLOOD CREATINE PHOSPHOKINASE INCREASED 1 0.0000
451 PSYCHOTIC DISORDER 1 0.0000
452 DISEASE PROGRESSION 4 0.0000
453 GASTROINTESTINAL DISORDER 3 0.0000
454 APHASIA 1 0.0000
455 EMOTIONAL DISTRESS 4 0.0000
456 ILL-DEFINED DISORDER 2 0.0000
457 OEDEMA PERIPHERAL 4 0.0000
458 VERTIGO 2 0.0000
459 ACUTE KIDNEY INJURY 5 0.0000
460 INJECTION SITE RASH 1 0.0000
461 CHEST PAIN 6 0.0000
462 LIMB DISCOMFORT 1 0.0000
463 WEIGHT DECREASED 9 0.0000
464 METABOLIC ACIDOSIS 1 0.0000
465 HIP FRACTURE 1 0.0000
466 CHOLELITHIASIS 1 0.0000
467 DYSPEPSIA 3 0.0000
468 HEART RATE INCREASED 3 0.0000
469 EXPIRED PRODUCT ADMINISTERED 1 0.0000
470 SKIN DISORDER 1 0.0000
471 URINARY RETENTION 1 0.0000
472 NEOPLASM MALIGNANT 2 0.0000
473 EYE PRURITUS 1 0.0000
474 TYPE 2 DIABETES MELLITUS 1 0.0000
475 TRANSIENT ISCHAEMIC ATTACK 1 0.0000
476 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 1 0.0000
477 HEPATIC ENZYME INCREASED 2 0.0000
478 HYPOXIA 1 0.0000
479 LYMPHADENOPATHY 1 0.0000
480 PLATELET COUNT DECREASED 3 0.0000
481 INCORRECT ROUTE OF DRUG ADMINISTRATION 1 0.0000
482 CEREBRAL HAEMORRHAGE 1 0.0000
483 MOBILITY DECREASED 2 0.0000
484 INFECTION 4 0.0000
485 WRONG TECHNIQUE IN DRUG USAGE PROCESS 1 0.0000
486 HYPERGLYCAEMIA 1 0.0000
487 HYPERSENSITIVITY 5 0.0000
488 INFLUENZA 3 0.0000
489 WEIGHT INCREASED 6 0.0000
490 INTESTINAL OBSTRUCTION 1 0.0000
491 RHEUMATOID ARTHRITIS 3 0.0000
492 ANAEMIA 5 0.0000
493 WHITE BLOOD CELL COUNT INCREASED 1 0.0000
494 PALPITATIONS 3 0.0000
495 ARTHRITIS 2 0.0000
496 CONFUSIONAL STATE 4 0.0000
497 EXTRA DOSE ADMINISTERED 1 0.0000
498 DRY MOUTH 2 0.0000
499 BLINDNESS 1 0.0000
500 NEUTROPHIL COUNT DECREASED 1 0.0000
501 OSTEOPOROSIS 1 0.0000
502 VISUAL IMPAIRMENT 3 0.0000
503 RHABDOMYOLYSIS 1 0.0000
504 POLLAKIURIA 1 0.0000
505 ABDOMINAL DISCOMFORT 4 0.0000
506 MYALGIA 4 0.0000
507 BALANCE DISORDER 2 0.0000
508 MYOCARDIAL INFARCTION 4 0.0000
509 CONSTIPATION 5 0.0000
510 RENAL FAILURE 3 0.0000
511 LIVER DISORDER 1 0.0000
512 DEHYDRATION 3 0.0000
513 THERAPEUTIC RESPONSE UNEXPECTED 1 0.0000
514 THERAPY NON-RESPONDER 1 0.0000
515 LOWER RESPIRATORY TRACT INFECTION 1 0.0000
516 DEPRESSION 5 0.0000
517 VISION BLURRED 3 0.0000
518 SKIN IRRITATION 1 0.0000
519 HYPOKALAEMIA 1 0.0000
520 DECREASED APPETITE 5 0.0000
521 ABDOMINAL PAIN 5 0.0000
522 COGNITIVE DISORDER 1 0.0000
523 SWELLING 2 0.0000
524 PRODUCT USE ISSUE 4 0.0000
525 DYSPNOEA 12 0.0000
526 ARRHYTHMIA 1 0.0000
527 DYSPHAGIA 2 0.0000
528 DISEASE RECURRENCE 1 0.0000
529 RENAL CANCER 1 0.0000
530 MIGRAINE 2 0.0000
531 HYPOGLYCAEMIA 1 0.0000
532 PRODUCT DOSE OMISSION ISSUE 6 0.0000
533 HYPOAESTHESIA 3 0.0000
534 SYNCOPE 2 0.0000
535 PAIN 12 0.0000
536 THERAPY CESSATION 1 0.0000
537 PERIPHERAL SWELLING 3 0.0000
538 ABDOMINAL PAIN UPPER 4 0.0000
539 FATIGUE 15 0.0000
540 HEADACHE 12 0.0000
541 NERVOUSNESS 1 0.0000
542 HAEMORRHAGE 2 0.0000
543 MUSCULOSKELETAL PAIN 1 0.0000
544 PARAESTHESIA 3 0.0000
545 PANCREATITIS 1 0.0000
546 DRUG EFFECT DECREASED 1 0.0000
547 TREATMENT NONCOMPLIANCE 1 0.0000
548 DRUG INEFFECTIVE 24 0.0000
549 DRUG DOSE OMISSION 3 0.0000
550 FALL 6 0.0000
551 MEDICATION ERROR 1 0.0000
552 URTICARIA 3 0.0000
553 HYPONATRAEMIA 1 0.0000
554 FLATULENCE 1 0.0000
555 EYE IRRITATION 1 0.0000
556 PRODUCT SUBSTITUTION ISSUE 1 0.0000
557 GENERAL PHYSICAL HEALTH DETERIORATION 2 0.0000
558 CHILLS 2 0.0000
559 WHEEZING 1 0.0000
560 ARTHRALGIA 7 0.0000
561 CATARACT 1 0.0000
562 FEELING ABNORMAL 4 0.0000
563 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 3 0.0000
564 NASOPHARYNGITIS 3 0.0000
565 ASTHENIA 6 0.0000
566 BLOOD GLUCOSE INCREASED 3 0.0000
567 GAIT DISTURBANCE 3 0.0000
568 LOSS OF CONSCIOUSNESS 2 0.0000
569 RHINORRHOEA 1 0.0000
570 PRODUCT DOSE OMISSION 1 0.0000
571 ALOPECIA 3 0.0000
572 BLOOD PRESSURE DECREASED 1 0.0000
573 INJECTION SITE PRURITUS 1 0.0000
574 NEUTROPENIA 2 0.0000
575 COUGH 4 0.0000
576 SLEEP DISORDER 1 0.0000
577 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1 0.0000
578 THERAPY INTERRUPTED 1 0.0000
579 NAUSEA 11 0.0000
580 RESPIRATORY FAILURE 1 0.0000
581 AGITATION 1 0.0000
582 CONDITION AGGRAVATED 4 0.0000
583 DIABETES MELLITUS 1 0.0000
584 HOSPITALISATION 2 0.0000
585 BACK PAIN 3 0.0000
586 DRUG DOSE OMISSION BY DEVICE 1 0.0000
587 DEATH 11 0.0000
588 THROMBOSIS 1 0.0000
589 DIARRHOEA 8 0.0000
590 PNEUMONIA 4 0.0000
591 TREMOR 2 0.0000
592 DIZZINESS 6 0.0000
593 GASTROINTESTINAL HAEMORRHAGE 1 0.0000
594 CEREBROVASCULAR ACCIDENT 2 0.0000
595 PRODUCT STORAGE ERROR 1 0.0000
596 OFF LABEL USE 10 0.0000
597 INTENTIONAL PRODUCT USE ISSUE 1 0.0000
598 MALAISE 5 0.0000
599 COVID-19 2 0.0000
600 DRUG WITHDRAWAL SYNDROME 1 0.0000
601 MATERNAL EXPOSURE DURING PREGNANCY 1 0.0000
602 MUSCLE SPASMS 2 0.0000
603 ADVERSE EVENT 1 0.0000
604 BREAST CANCER 1 0.0000
605 VOMITING 5 0.0000
606 HYPOTENSION 2 0.0000
607 SOMNOLENCE 2 0.0000
608 MALIGNANT NEOPLASM PROGRESSION 1 0.0000
609 HYPERTENSION 2 0.0000
610 WHITE BLOOD CELL COUNT DECREASED 1 0.0000
611 SEPSIS 1 0.0000
612 THROMBOCYTOPENIA 1 0.0000
613 PYREXIA 3 0.0000
614 SEIZURE 1 0.0000
615 JOINT SWELLING 1 0.0000
616 PRODUCT USE IN UNAPPROVED INDICATION 2 0.0000
617 INJECTION SITE ERYTHEMA 1 0.0000
618 PRODUCT QUALITY ISSUE 1 0.0000
619 BLOOD PRESSURE INCREASED 1 0.0000
620 DRUG DEPENDENCE 1 0.0000
621 TOXICITY TO VARIOUS AGENTS 1 0.0000
622 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1 0.0000
623 INCORRECT DOSE ADMINISTERED 1 0.0000
624 PAIN IN EXTREMITY 1 0.0000